Tsingyuan Ventures is a California based venture capital investment firm that invests primarily in technology-based startups in the United States and China. The company’s investment portfolio includes artificial intelligence, biotech, consumer, and enterprise product startups. The company finds innovative and upcoming technology startups and is analyzed by their team of experts to find investment opportunities.
Their investment portfolio include companies like Zoom (a video conferencing service), Stimwave (MRI-safe neuro stimulation device for the treatment of chronic peripheral nerve pain), Subtle Medical (AI technology to enhance PET scan images), WeRide (first commercial taxi service in China), and Ginkgo Bioworks (creating animal cells for immunotherapies and antibodies).
The company is a successor to TEEC Angel Fund and was founded on January 1, 2017. It is headquartered in Los Altos, California with offices at San Francisco and Silicon Valley. The team consists of experts from many fields including BioTech, Artificial Intelligence, and cybersecurity. As of February 2019, their investment team comprises 7 Ph.D. graduates and hold a collection of 150 patents.
Timeline
Invested in
Associated Investment Funds
Accelerator Batches
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Funding Rounds Participated In
Further Resources
Tsingyuan Ventures - Investor in Los Altos, California - Ask For Funding
Web
Tsingyuan Ventures Rebrands As Foothill Ventures And Closes $100M Fund
FinSMEs
Web
August 4, 2021
